Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rifampicin resistance and associated factors of Mycobacterium tuberculosis among pulmonary tuberculosis-suspected patients in the Amhara National Regional State Comprehensive Specialized Hospitals, Ethiopia.

PloS one·2026
Same author

Hospital-based surveillance suggested a high frequency of congenital rubella syndrome and the presence of genetically diverse genotype 2B rubella virus strains in Ethiopia.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Recent HIV infection among women and men enrolling to care in urban clinics in Ethiopia.

BMC infectious diseases·2026
Same author

Methicillin and inducible clindamycin resistance in Gram-positive cocci among GeneXpert-positive pulmonary tuberculosis patients and apparently healthy individuals in Northwest Ethiopia.

BMC microbiology·2026
Same author

Retraction notice to "Non-tuberculous mycobacterial infections among patients with suspected or confirmed pulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis" [IJID Reg 16 (2025) 100692].

IJID regions·2026
Same author

Occult Hepatitis B Virus Infection Among Blood Donors in the Capital City of Addis Ababa, Ethiopia: <i>Implications for Blood Transfusion Safety</i>.

Frontiers in gastroenterology (Lausanne, Switzerland)·2026

Related Experiment Video

Updated: May 9, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Tuberculosis lymphadenitis in Ethiopia.

Fantahun Biadglegne1, Weghata Tesfaye, Belay Anagaw

  • 1Faculty of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia. fantahun.degeneh@gmail.com

Japanese Journal of Infectious Diseases
|July 26, 2013
PubMed
Summary
This summary is machine-generated.

Ethiopia faces a high burden of tuberculosis (TB), particularly extrapulmonary TB (EPTB) and TB lymphadenitis (TBL). Unsatisfactory management of multidrug-resistant (MDR) TB highlights the need for improved diagnostics and timely treatment.

Related Experiment Videos

Last Updated: May 9, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Area of Science:

  • Public Health
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Tuberculosis (TB) presents a significant public health challenge in Ethiopia, ranking 7th globally in disease burden.
  • Ethiopia holds the 3rd global rank for extrapulmonary TB (EPTB) cases, with TB lymphadenitis (TBL) being the most prevalent form.
  • Limited availability of routine pathological services, culture, and drug susceptibility testing hinders effective management, particularly for multidrug-resistant (MDR) TB.

Purpose of the Study:

  • To highlight the critical public health issue of TB in Ethiopia.
  • To emphasize the challenges in diagnosing and managing EPTB, especially TBL and MDR-TB.
  • To underscore the importance of clinical suspicion, timely diagnostics, and prompt treatment initiation for successful TB management.

Main Methods:

  • Review of global and national TB statistics.
  • Analysis of EPTB and TBL prevalence in Ethiopia.
  • Assessment of current diagnostic and treatment limitations for TB and MDR-TB.

Main Results:

  • Ethiopia has a high incidence of TB (378 per 100,000 population in 2007).
  • EPTB constitutes 36% of TB cases, with TBL accounting for 80% of EPTB.
  • Current diagnostic and treatment capabilities for MDR-TB are unsatisfactory.

Conclusions:

  • Effective management of MDR-TB and TBL in Ethiopia requires a high index of clinical suspicion.
  • Timely diagnostic methods and prompt initiation of specific anti-TB treatment are crucial.
  • Addressing the lack of routine pathological services and drug susceptibility testing is essential for improving TB care.